In the present work we have identified purinergic receptors present in several GC-derived cell lines and also in biopsies from patients diagnosed with GC, finding that the expression pattern varies between the different cell lines, and between healthy and tumor cells, and biopsies. This evidence concerns the gene P2RX3 and neoplasm.